PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels

Bo Yoon Park, Jae Han Jeon, Younghoon Go, Hye Jin Ham, Jeong Eun Kim, Eun Kyung Yoo, Woong Hee Kwon, Nam Ho Jeoung, Yong Hyun Jeon, Seung Hoi Koo, Byung Gyu Kim, Ling He, Keun Gyu Park, Robert A. Harris, In Kyu Lee

Research output: Contribution to journalArticle

Abstract

In fasting or diabetes, gluconeogenic genes are transcriptionally activated by glucagon stimulation of the cAMP-protein kinase A (PKA)-CREB signaling pathway. Previous work showed pyruvate dehydrogenase kinase (PDK) inhibition in skeletal muscle increases pyruvate oxidation, which limits the availability of gluconeogenic substrates in the liver. However, this study found upregulation of hepatic PDK4 promoted glucagon-mediated expression of gluconeogenic genes, whereas knockdown or inhibition of hepatic PDK4 caused the opposite effect on gluconeogenic gene expression and decreased hepatic glucose production. Mechanistically, PDK4 deficiency decreased ATP levels, thus increasing phosphorylated AMPK (p-AMPK), which increased p-AMPK-sensitive phosphorylation of cyclic nucleotide phosphodiesterase 4B (p-PDE4B). This reduced cAMP levels and consequently p-CREB. Metabolic flux analysis showed that the reduction in ATP was a consequence of a diminished rate of fatty acid oxidation (FAO). However, overexpression of PDK4 increased FAO and increased ATP levels, which decreased p-AMPK and p-PDE4B and allowed greater accumulation of cAMP and p-CREB. The latter were abrogated by the FAO inhibitor etomoxir, suggesting a critical role for PDK4 in FAO stimulation and the regulation of cAMP levels. This finding strengthens the possibility of PDK4 as a target against diabetes.

Original languageEnglish (US)
Pages (from-to)2054-2068
Number of pages15
JournalDiabetes
Volume67
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Glucagon
AMP-Activated Protein Kinases
Fatty Acids
Type 4 Cyclic Nucleotide Phosphodiesterase
Adenosine Triphosphate
Liver
Metabolic Flux Analysis
Gene Knockdown Techniques
Cyclic Nucleotides
Cyclic AMP-Dependent Protein Kinases
Pyruvic Acid
Fasting
Skeletal Muscle
Up-Regulation
Phosphorylation
Gene Expression
Glucose
Genes
Inhibition (Psychology)

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Park, B. Y., Jeon, J. H., Go, Y., Ham, H. J., Kim, J. E., Yoo, E. K., ... Lee, I. K. (2018). PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. Diabetes, 67(10), 2054-2068. https://doi.org/10.2337/db17-1529

PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. / Park, Bo Yoon; Jeon, Jae Han; Go, Younghoon; Ham, Hye Jin; Kim, Jeong Eun; Yoo, Eun Kyung; Kwon, Woong Hee; Jeoung, Nam Ho; Jeon, Yong Hyun; Koo, Seung Hoi; Kim, Byung Gyu; He, Ling; Park, Keun Gyu; Harris, Robert A.; Lee, In Kyu.

In: Diabetes, Vol. 67, No. 10, 01.10.2018, p. 2054-2068.

Research output: Contribution to journalArticle

Park, BY, Jeon, JH, Go, Y, Ham, HJ, Kim, JE, Yoo, EK, Kwon, WH, Jeoung, NH, Jeon, YH, Koo, SH, Kim, BG, He, L, Park, KG, Harris, RA & Lee, IK 2018, 'PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels', Diabetes, vol. 67, no. 10, pp. 2054-2068. https://doi.org/10.2337/db17-1529
Park BY, Jeon JH, Go Y, Ham HJ, Kim JE, Yoo EK et al. PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. Diabetes. 2018 Oct 1;67(10):2054-2068. https://doi.org/10.2337/db17-1529
Park, Bo Yoon ; Jeon, Jae Han ; Go, Younghoon ; Ham, Hye Jin ; Kim, Jeong Eun ; Yoo, Eun Kyung ; Kwon, Woong Hee ; Jeoung, Nam Ho ; Jeon, Yong Hyun ; Koo, Seung Hoi ; Kim, Byung Gyu ; He, Ling ; Park, Keun Gyu ; Harris, Robert A. ; Lee, In Kyu. / PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels. In: Diabetes. 2018 ; Vol. 67, No. 10. pp. 2054-2068.
@article{14d1d18bd4584642a6ccbcd34b101b38,
title = "PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels",
abstract = "In fasting or diabetes, gluconeogenic genes are transcriptionally activated by glucagon stimulation of the cAMP-protein kinase A (PKA)-CREB signaling pathway. Previous work showed pyruvate dehydrogenase kinase (PDK) inhibition in skeletal muscle increases pyruvate oxidation, which limits the availability of gluconeogenic substrates in the liver. However, this study found upregulation of hepatic PDK4 promoted glucagon-mediated expression of gluconeogenic genes, whereas knockdown or inhibition of hepatic PDK4 caused the opposite effect on gluconeogenic gene expression and decreased hepatic glucose production. Mechanistically, PDK4 deficiency decreased ATP levels, thus increasing phosphorylated AMPK (p-AMPK), which increased p-AMPK-sensitive phosphorylation of cyclic nucleotide phosphodiesterase 4B (p-PDE4B). This reduced cAMP levels and consequently p-CREB. Metabolic flux analysis showed that the reduction in ATP was a consequence of a diminished rate of fatty acid oxidation (FAO). However, overexpression of PDK4 increased FAO and increased ATP levels, which decreased p-AMPK and p-PDE4B and allowed greater accumulation of cAMP and p-CREB. The latter were abrogated by the FAO inhibitor etomoxir, suggesting a critical role for PDK4 in FAO stimulation and the regulation of cAMP levels. This finding strengthens the possibility of PDK4 as a target against diabetes.",
author = "Park, {Bo Yoon} and Jeon, {Jae Han} and Younghoon Go and Ham, {Hye Jin} and Kim, {Jeong Eun} and Yoo, {Eun Kyung} and Kwon, {Woong Hee} and Jeoung, {Nam Ho} and Jeon, {Yong Hyun} and Koo, {Seung Hoi} and Kim, {Byung Gyu} and Ling He and Park, {Keun Gyu} and Harris, {Robert A.} and Lee, {In Kyu}",
year = "2018",
month = "10",
day = "1",
doi = "10.2337/db17-1529",
language = "English (US)",
volume = "67",
pages = "2054--2068",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "10",

}

TY - JOUR

T1 - PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels

AU - Park, Bo Yoon

AU - Jeon, Jae Han

AU - Go, Younghoon

AU - Ham, Hye Jin

AU - Kim, Jeong Eun

AU - Yoo, Eun Kyung

AU - Kwon, Woong Hee

AU - Jeoung, Nam Ho

AU - Jeon, Yong Hyun

AU - Koo, Seung Hoi

AU - Kim, Byung Gyu

AU - He, Ling

AU - Park, Keun Gyu

AU - Harris, Robert A.

AU - Lee, In Kyu

PY - 2018/10/1

Y1 - 2018/10/1

N2 - In fasting or diabetes, gluconeogenic genes are transcriptionally activated by glucagon stimulation of the cAMP-protein kinase A (PKA)-CREB signaling pathway. Previous work showed pyruvate dehydrogenase kinase (PDK) inhibition in skeletal muscle increases pyruvate oxidation, which limits the availability of gluconeogenic substrates in the liver. However, this study found upregulation of hepatic PDK4 promoted glucagon-mediated expression of gluconeogenic genes, whereas knockdown or inhibition of hepatic PDK4 caused the opposite effect on gluconeogenic gene expression and decreased hepatic glucose production. Mechanistically, PDK4 deficiency decreased ATP levels, thus increasing phosphorylated AMPK (p-AMPK), which increased p-AMPK-sensitive phosphorylation of cyclic nucleotide phosphodiesterase 4B (p-PDE4B). This reduced cAMP levels and consequently p-CREB. Metabolic flux analysis showed that the reduction in ATP was a consequence of a diminished rate of fatty acid oxidation (FAO). However, overexpression of PDK4 increased FAO and increased ATP levels, which decreased p-AMPK and p-PDE4B and allowed greater accumulation of cAMP and p-CREB. The latter were abrogated by the FAO inhibitor etomoxir, suggesting a critical role for PDK4 in FAO stimulation and the regulation of cAMP levels. This finding strengthens the possibility of PDK4 as a target against diabetes.

AB - In fasting or diabetes, gluconeogenic genes are transcriptionally activated by glucagon stimulation of the cAMP-protein kinase A (PKA)-CREB signaling pathway. Previous work showed pyruvate dehydrogenase kinase (PDK) inhibition in skeletal muscle increases pyruvate oxidation, which limits the availability of gluconeogenic substrates in the liver. However, this study found upregulation of hepatic PDK4 promoted glucagon-mediated expression of gluconeogenic genes, whereas knockdown or inhibition of hepatic PDK4 caused the opposite effect on gluconeogenic gene expression and decreased hepatic glucose production. Mechanistically, PDK4 deficiency decreased ATP levels, thus increasing phosphorylated AMPK (p-AMPK), which increased p-AMPK-sensitive phosphorylation of cyclic nucleotide phosphodiesterase 4B (p-PDE4B). This reduced cAMP levels and consequently p-CREB. Metabolic flux analysis showed that the reduction in ATP was a consequence of a diminished rate of fatty acid oxidation (FAO). However, overexpression of PDK4 increased FAO and increased ATP levels, which decreased p-AMPK and p-PDE4B and allowed greater accumulation of cAMP and p-CREB. The latter were abrogated by the FAO inhibitor etomoxir, suggesting a critical role for PDK4 in FAO stimulation and the regulation of cAMP levels. This finding strengthens the possibility of PDK4 as a target against diabetes.

UR - http://www.scopus.com/inward/record.url?scp=85054779774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054779774&partnerID=8YFLogxK

U2 - 10.2337/db17-1529

DO - 10.2337/db17-1529

M3 - Article

C2 - 30065033

AN - SCOPUS:85054779774

VL - 67

SP - 2054

EP - 2068

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 10

ER -